Stableford Capital II’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $976K | Buy |
5,129
+594
| +13% | +$113K | 0.37% | 80 |
|
|
2025
Q1 | $785K | Sell |
4,535
-376
| -8% | -$65K | 0.33% | 84 |
|
|
2024
Q4 | $873K | Sell |
4,911
-79
| -2% | -$14K | 0.34% | 87 |
|
|
2024
Q3 | $969K | Sell |
4,990
-274
| -5% | -$53.2K | 0.39% | 92 |
|
|
2024
Q2 | $923K | Buy |
5,264
+226
| +4% | +$39.6K | 0.36% | 94 |
|
|
2024
Q1 | $917K | Sell |
5,038
-331
| -6% | -$60.3K | 0.37% | 80 |
|
|
2023
Q4 | $879K | Sell |
5,369
-140
| -3% | -$22.9K | 0.38% | 71 |
|
|
2023
Q3 | $800K | Sell |
5,509
-648
| -11% | -$94.1K | 0.37% | 63 |
|
|
2023
Q2 | $932K | Buy |
+6,157
| New | +$932K | 0.41% | 50 |
|
|
2023
Q1 | – | Sell |
-4,766
| Closed | -$770K | – | 68 |
|
|
2022
Q4 | $770K | Sell |
4,766
-527
| -10% | -$85.2K | 0.42% | 74 |
|
|
2022
Q3 | $778K | Buy |
5,293
+220
| +4% | +$32.3K | 0.38% | 63 |
|
|
2022
Q2 | $700K | Sell |
5,073
-2,347
| -32% | -$324K | 0.32% | 86 |
|
|
2022
Q1 | $1.29M | Buy |
+7,420
| New | +$1.29M | 0.54% | 40 |
|
|
2019
Q1 | – | Sell |
-3,541
| Closed | -$326K | – | 93 |
|
|
2018
Q4 | $326K | Sell |
3,541
-1,323
| -27% | -$122K | 0.35% | 70 |
|
|
2018
Q3 | $460K | Sell |
4,864
-48
| -1% | -$4.54K | 0.3% | 67 |
|
|
2018
Q2 | $455K | Buy |
4,912
+77
| +2% | +$7.13K | 0.3% | 62 |
|
|
2018
Q1 | $458K | Sell |
4,835
-33
| -0.7% | -$3.13K | 0.32% | 59 |
|
|
2017
Q4 | $471K | Sell |
4,868
-111
| -2% | -$10.7K | 0.32% | 62 |
|
|
2017
Q3 | $442K | Buy |
+4,979
| New | +$442K | 0.32% | 70 |
|